Is Sage recalled?
192 FDA recalls mention Sage. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Sage.
Class III · Low risk Ongoing Jun 3, 2026
Reason Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
Class III · Low risk Ongoing May 4, 2026
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Ongoing Aug 18, 2025
Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a…
Class II · Moderate risk Ongoing Aug 18, 2025
Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a…
Class II · Moderate risk Ongoing Aug 18, 2025
Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a…
Class II · Moderate risk Ongoing Aug 18, 2025
Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a…
Class II · Moderate risk Ongoing Aug 18, 2025
Reason Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a…
Class I · High risk Ongoing Jun 2, 2025
Reason Microbial contamination of non-sterile products: tablets may exhibit black spots due to microbial contamination.
Class II · Moderate risk Ongoing Nov 1, 2024
Reason cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Class II · Moderate risk Ongoing Nov 1, 2024
Reason cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Class II · Moderate risk Ongoing Nov 1, 2024
Reason cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Class II · Moderate risk Ongoing Nov 1, 2024
Reason cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Class I · High risk Ongoing May 28, 2024
Reason Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Class I · High risk Ongoing May 28, 2024
Reason Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Class II · Moderate risk Ongoing Apr 25, 2024
Reason Presence of Particulate Matter: Potential for black particulates in the drug product.
Class II · Moderate risk Ongoing Apr 17, 2024
Reason Failed Dissolution Specifications
Class II · Moderate risk Ongoing Mar 26, 2024
Reason Failed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability…
Class II · Moderate risk Terminated Jan 15, 2024
Reason Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Class II · Moderate risk Ongoing Jul 11, 2023
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing Jul 11, 2023
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing Jul 11, 2023
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing May 19, 2023
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing May 19, 2023
Reason Lack of Assurance of Sterility
Class II · Moderate risk Ongoing May 19, 2023
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated Feb 28, 2023
Reason Labeling: Not elsewhere classified